Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase 1 cohorts of CheckMate 143.
about
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase 1 cohorts of CheckMate 143.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Nivolumab with or without ipil ...... se 1 cohorts of CheckMate 143.
@en
Nivolumab with or without ipil ...... se 1 cohorts of CheckMate 143.
@nl
type
label
Nivolumab with or without ipil ...... se 1 cohorts of CheckMate 143.
@en
Nivolumab with or without ipil ...... se 1 cohorts of CheckMate 143.
@nl
prefLabel
Nivolumab with or without ipil ...... se 1 cohorts of CheckMate 143.
@en
Nivolumab with or without ipil ...... se 1 cohorts of CheckMate 143.
@nl
P2093
P2860
P356
P1433
P1476
Nivolumab with or without ipil ...... se 1 cohorts of CheckMate 143.
@en
P2093
Alfredo Voloschin
Antonio Omuro
Christopher T Harbison
Gordana Vlahovic
Joachim Baehring
John H Sampsonc
Keith L Ligon
Lewis Strauss
Michael Lim
Prashni Paliwal
P2860
P356
10.1093/NEUONC/NOX208
P577
2017-10-28T00:00:00Z